Total Payments
$467,676
2024 Payments
$18,862
Companies
15
Transactions
937
Medicare Patients
20,282
Medicare Billing
$1.6M
Payment Breakdown by Category
Research$453,776 (97.0%)
Gifts$8,083 (1.7%)
Education$5,275 (1.1%)
Food & Beverage$540.91 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $453,776 | 903 | 97.0% |
| Gift | $8,083 | 1 | 1.7% |
| Education | $5,275 | 4 | 1.1% |
| Food and Beverage | $540.91 | 29 | 0.1% |
Payments by Type
Research
$453,776
903 transactions
General
$13,900
34 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alcon Research LLC | $405,956 | 887 | $0 (2022) |
| Genentech, Inc. | $21,461 | 7 | $0 (2021) |
| EyePoint Pharmaceuticals US, Inc. | $18,862 | 1 | $0 (2024) |
| Allergan, Inc. | $10,707 | 19 | $0 (2020) |
| Carl Zeiss Meditec, Inc. | $8,083 | 1 | $0 (2020) |
| Aerie Pharmaceuticals, Inc. | $2,241 | 5 | $0 (2020) |
| Shire North American Group Inc | $104.72 | 4 | $0 (2019) |
| Johnson & Johnson Surgical Vision, Inc. | $84.42 | 4 | $0 (2019) |
| Mallinckrodt Hospital Products Inc. | $50.56 | 2 | $0 (2023) |
| Eyevance Pharmaceuticals LLC | $34.09 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18,862 | 1 | EyePoint Pharmaceuticals US, Inc. ($18,862) |
| 2023 | $59.78 | 2 | Mallinckrodt Hospital Products Inc. ($36.20) |
| 2022 | $65,503 | 172 | Alcon Research LLC ($65,456) |
| 2021 | $224,691 | 500 | Alcon Research LLC ($203,345) |
| 2020 | $23,137 | 30 | Alcon Research LLC ($9,478) |
| 2019 | $38,795 | 84 | Alcon Research LLC ($37,525) |
| 2018 | $66,022 | 104 | Alcon Research Ltd ($65,766) |
| 2017 | $30,605 | 44 | Alcon Research Ltd ($24,385) |
All Payment Transactions
937 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/10/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | — | Cash or cash equivalent | $18,862.05 | Research |
| Study: A Phase 2, Multicenter, Prospective, Randomized, Double-Masked, Parallel Study of EYP-1901, a Tyrosine Kinase Inhibitor (TKI), Compared to Aflibercept in Subjects With Diabetic Macular Edema (DME) • Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 10/24/2023 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: Ophthalmology | ||||||
| 06/20/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $36.20 | General |
| Category: IMMUNOLOGY | ||||||
| 11/02/2022 | Alcon Research LLC | Acrysof, IQ ReSTOR (Device) | — | Cash or cash equivalent | $362.50 | Research |
| Study: Post Approval Study of the AcrySof IQ ReSTOR Toric IOL • Category: Ophthalmology | ||||||
| 11/02/2022 | Alcon Research LLC | Acrysof, IQ ReSTOR (Device) | — | Cash or cash equivalent | $362.50 | Research |
| Study: Post Approval Study of the AcrySof IQ ReSTOR Toric IOL • Category: Ophthalmology | ||||||
| 10/12/2022 | Alcon Research LLC | Acrysof, IQ ReSTOR (Device) | — | Cash or cash equivalent | $362.50 | Research |
| Study: Post Approval Study of the AcrySof IQ ReSTOR Toric IOL • Category: Ophthalmology | ||||||
| 10/12/2022 | Alcon Research LLC | Acrysof, IQ ReSTOR (Device) | — | Cash or cash equivalent | $362.50 | Research |
| Study: Post Approval Study of the AcrySof IQ ReSTOR Toric IOL • Category: Ophthalmology | ||||||
| 10/05/2022 | Alcon Research LLC | Acrysof, IQ ReSTOR (Device) | — | Cash or cash equivalent | $362.50 | Research |
| Study: Post Approval Study of the AcrySof IQ ReSTOR Toric IOL • Category: Ophthalmology | ||||||
| 10/05/2022 | Alcon Research LLC | Acrysof, IQ ReSTOR (Device) | — | Cash or cash equivalent | $362.50 | Research |
| Study: Post Approval Study of the AcrySof IQ ReSTOR Toric IOL • Category: Ophthalmology | ||||||
| 09/28/2022 | Alcon Research LLC | Acrysof, IQ ReSTOR (Device) | — | Cash or cash equivalent | $362.50 | Research |
| Study: Post Approval Study of the AcrySof IQ ReSTOR Toric IOL • Category: Ophthalmology | ||||||
| 09/28/2022 | Alcon Research LLC | Acrysof, IQ ReSTOR (Device) | — | Cash or cash equivalent | $362.50 | Research |
| Study: Post Approval Study of the AcrySof IQ ReSTOR Toric IOL • Category: Ophthalmology | ||||||
| 08/24/2022 | Alcon Research LLC | Acrysof, IQ ReSTOR (Device) | — | Cash or cash equivalent | $362.50 | Research |
| Study: Post Approval Study of the AcrySof IQ ReSTOR Toric IOL • Category: Ophthalmology | ||||||
| 08/24/2022 | Alcon Research LLC | Acrysof, IQ ReSTOR (Device) | — | Cash or cash equivalent | $362.50 | Research |
| Study: Post Approval Study of the AcrySof IQ ReSTOR Toric IOL • Category: Ophthalmology | ||||||
| 08/24/2022 | Alcon Research LLC | Acrysof, IQ ReSTOR (Device) | — | Cash or cash equivalent | $362.50 | Research |
| Study: Post Approval Study of the AcrySof IQ ReSTOR Toric IOL • Category: Ophthalmology | ||||||
| 08/03/2022 | Alcon Research LLC | Acrysof, IQ ReSTOR (Device) | — | Cash or cash equivalent | $362.50 | Research |
| Study: Post Approval Study of the AcrySof IQ ReSTOR Toric IOL • Category: Ophthalmology | ||||||
| 08/03/2022 | Alcon Research LLC | Acrysof, IQ ReSTOR (Device) | — | Cash or cash equivalent | $362.50 | Research |
| Study: Post Approval Study of the AcrySof IQ ReSTOR Toric IOL • Category: Ophthalmology | ||||||
| 08/03/2022 | Alcon Research LLC | Acrysof, IQ ReSTOR (Device) | — | Cash or cash equivalent | $362.50 | Research |
| Study: Post Approval Study of the AcrySof IQ ReSTOR Toric IOL • Category: Ophthalmology | ||||||
| 07/27/2022 | Alcon Research LLC | Acrysof, IQ ReSTOR (Device) | — | Cash or cash equivalent | $362.50 | Research |
| Study: Post Approval Study of the AcrySof IQ ReSTOR Toric IOL • Category: Ophthalmology | ||||||
| 07/27/2022 | Alcon Research LLC | Acrysof, IQ ReSTOR (Device) | — | Cash or cash equivalent | $362.50 | Research |
| Study: Post Approval Study of the AcrySof IQ ReSTOR Toric IOL • Category: Ophthalmology | ||||||
| 07/20/2022 | Alcon Research LLC | Acrysof, IQ ReSTOR (Device) | — | Cash or cash equivalent | $362.50 | Research |
| Study: Post Approval Study of the AcrySof IQ ReSTOR Toric IOL • Category: Ophthalmology | ||||||
| 07/06/2022 | Alcon Research LLC | Acrysof, IQ ReSTOR (Device) | — | Cash or cash equivalent | $362.50 | Research |
| Study: Post Approval Study of the AcrySof IQ ReSTOR Toric IOL • Category: Ophthalmology | ||||||
| 07/06/2022 | Alcon Research LLC | Acrysof, IQ ReSTOR (Device) | — | Cash or cash equivalent | $362.50 | Research |
| Study: Post Approval Study of the AcrySof IQ ReSTOR Toric IOL • Category: Ophthalmology | ||||||
| 07/06/2022 | Alcon Research LLC | Acrysof, IQ ReSTOR (Device) | — | Cash or cash equivalent | $362.50 | Research |
| Study: Post Approval Study of the AcrySof IQ ReSTOR Toric IOL • Category: Ophthalmology | ||||||
| 07/06/2022 | Alcon Research LLC | Acrysof, IQ ReSTOR (Device) | — | Cash or cash equivalent | $362.50 | Research |
| Study: Post Approval Study of the AcrySof IQ ReSTOR Toric IOL • Category: Ophthalmology | ||||||
| 07/06/2022 | Alcon Research LLC | Acrysof, IQ ReSTOR (Device) | — | Cash or cash equivalent | $362.50 | Research |
| Study: Post Approval Study of the AcrySof IQ ReSTOR Toric IOL • Category: Ophthalmology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Post Approval Study of the AcrySof IQ ReSTOR Toric IOL | Alcon Research LLC | $268,802 | 664 |
| US Confirmatory Trial of Clareon IOL (Clareon UltraSert and Wagon Wheel) | Alcon Research Ltd | $65,766 | 95 |
| Post Approval Study of the AcrySof IQ ReSTOR Toric IOL (Models SND1T3-T6) | Alcon Research LLC | $27,873 | 58 |
| US Confirmatory Trial of Clareon IOL ( Clareon - UltraSert and Wagon Wheel) | Alcon Research Ltd | $24,385 | 35 |
| PATIENT EXPERIENCE AND PREFERENCE | Genentech, Inc. | $21,346 | 5 |
| A Phase 2, Multicenter, Prospective, Randomized, Double-Masked, Parallel Study of EYP-1901, a Tyrosine Kinase Inhibitor (TKI), Compared to Aflibercept in Subjects With Diabetic Macular Edema (DME) | EyePoint Pharmaceuticals US, Inc. | $18,862 | 1 |
| US Confirmatory Trial of Clareon IOL ( Clareon - UltraSert and Wagon Wheel) | Alcon Research LLC | $9,641 | 14 |
| Post Approval Study of the AcrySof IQ ReSTOR Toric IOLs | Alcon Research LLC | $6,478 | 18 |
| Efficacy and Safety of Bimatoprost Sustained-Release SR in Patients With Open-angle Glaucoma or Ocular Hypertension | Allergan Inc. | $6,199 | 6 |
| Verona study to understand patient impact | Alcon Research LLC | $3,000 | 2 |
| The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension | Allergan Inc. | $1,071 | 2 |
| The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension | Allergan, Inc. | $355.03 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 5,471 | 6,316 | $2.1M | $424,014 |
| 2022 | 18 | 5,117 | 5,973 | $1.9M | $406,159 |
| 2021 | 21 | 5,049 | 5,911 | $1.9M | $418,514 |
| 2020 | 20 | 4,645 | 5,401 | $1.8M | $399,151 |
Total Patients
20,282
Total Services
23,601
Medicare Billing
$1.6M
Procedure Codes
79
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 188 | 291 | $800,250 | $121,663 | 15.2% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 959 | 1,079 | $485,110 | $92,803 | 19.1% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 525 | 697 | $104,550 | $46,978 | 44.9% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2023 | 117 | 150 | $150,000 | $34,245 | 22.8% |
| 92134 | Imaging of retina | Office | 2023 | 978 | 1,094 | $109,400 | $30,356 | 27.7% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 552 | 595 | $59,500 | $28,502 | 47.9% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 213 | 213 | $95,850 | $18,473 | 19.3% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 1,098 | 1,236 | $98,880 | $13,562 | 13.7% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 221 | 296 | $38,950 | $8,828 | 22.7% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2023 | 12 | 13 | $35,750 | $7,466 | 20.9% |
| 92133 | Imaging of optic nerve | Office | 2023 | 216 | 225 | $22,500 | $5,748 | 25.5% |
| 92286 | Imaging of front third of eye using a special microscope | Office | 2023 | 166 | 171 | $38,475 | $4,805 | 12.5% |
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 21 | 33 | $9,200 | $3,973 | 43.2% |
| 92060 | Exam to measure eye deviation and range of motion | Office | 2023 | 66 | 72 | $5,400 | $3,528 | 65.3% |
| 92025 | Ct scan of cornea | Office | 2023 | 48 | 51 | $6,120 | $1,298 | 21.2% |
| 92071 | Fitting of contact lens for treatment of eye surface disease | Office | 2023 | 12 | 20 | $2,500 | $506.60 | 20.3% |
| 92002 | New patient problem focused exam of visual system | Office | 2023 | 14 | 14 | $5,740 | $497.91 | 8.7% |
| 92285 | Photography of content of eyes | Office | 2023 | 23 | 24 | $2,160 | $383.08 | 17.7% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 29 | 29 | $725.00 | $255.96 | 35.3% |
| 67820 | Removal of eyelashes using forceps | Office | 2023 | 13 | 13 | $1,300 | $143.38 | 11.0% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 161 | 254 | $698,500 | $106,851 | 15.3% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 926 | 1,062 | $445,420 | $96,116 | 21.6% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2022 | 138 | 177 | $177,000 | $42,185 | 23.8% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 445 | 599 | $89,850 | $41,136 | 45.8% |
| 92134 | Imaging of retina | Office | 2022 | 970 | 1,109 | $110,900 | $32,175 | 29.0% |
About Dr. William Rand, MD
Dr. William Rand, MD is a Specialist healthcare provider based in Pompano Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1295829927.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Rand, MD has received a total of $467,676 in payments from pharmaceutical and medical device companies, with $18,862 received in 2024. These payments were reported across 937 transactions from 15 companies. The most common payment nature is "" ($453,776).
As a Medicare-enrolled provider, Rand has provided services to 20,282 Medicare beneficiaries, totaling 23,601 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Ophthalmology
- Location Pompano Beach, FL
- Active Since 10/03/2006
- Last Updated 08/08/2016
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1295829927
Products in Payments
- Acrysof IQ ReSTOR IOL (Device) $203,345
- Acrysof, IQ ReSTOR (Device) $65,456
- ReSTOR (Device) $27,873
- EYP-1901 (Drug) $18,862
- CLAREON (Device) $9,641
- Acrysof IQ ReSTOR +3.0D IOL (Device) $6,478
- LUMIGAN (Drug) $6,243
- rocklatan (Drug) $2,219
- Lucentis (Biological) $115.65
- XIIDRA (Drug) $104.72
- ACTHAR (Biological) $50.56
- Tecnis 1-piece IOL (Device) $43.86
- Tecnis 3-piece IOL (Device) $40.56
- OZURDEX (Drug) $39.00
- Flarex (Drug) $34.09
- MIEBO (Drug) $23.58
- DUREZOL (Drug) $21.87
- Rocklatan (Drug) $21.81
- Cequa (Drug) $19.80
- Omidria (Drug) $13.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Pompano Beach
Dr. Sanford Silverman, M.d, M.D
Specialist — Payments: $143,292
Specialist $143,292
Dr. Paul Lapco, Md, MD
Specialist — Payments: $17,012
Specialist $17,012
Steven Naide, Md, MD
Specialist — Payments: $5,379
Specialist $5,379
Eric Johnson, Do, DO
Specialist — Payments: $4,068
Specialist $4,068
Mr. Adib Chidiac, M.d., P.a., Facog, M.D., P.A., FACOG
Specialist — Payments: $2,976
Specialist $2,976
Dr. Shahab Kidwai, M.d, M.D
Specialist — Payments: $2,150
Specialist $2,150